340 related articles for article (PubMed ID: 34868973)
1. Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
Zhang L; Ge Y; Gao Q; Zhao F; Cheng T; Li H; Xia Y
Front Oncol; 2021; 11():758921. PubMed ID: 34868973
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram.
Zhang L; Gao Q; Dou Y; Cheng T; Xia Y; Li H; Gao S
Front Oncol; 2024; 14():1345576. PubMed ID: 38577327
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
5. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
6. Machine learning model based on enhanced CT radiomics for the preoperative prediction of lymphovascular invasion in esophageal squamous cell carcinoma.
Wang Y; Bai G; Huang M; Chen W
Front Oncol; 2024; 14():1308317. PubMed ID: 38549935
[TBL] [Abstract][Full Text] [Related]
7. Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram.
Zhong J; Zhang C; Hu Y; Zhang J; Liu Y; Si L; Xing Y; Ding D; Geng J; Jiao Q; Zhang H; Yang G; Yao W
Eur Radiol; 2022 Sep; 32(9):6196-6206. PubMed ID: 35364712
[TBL] [Abstract][Full Text] [Related]
8. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
10. The value of machine learning based radiomics model in preoperative detection of perineural invasion in gastric cancer: a two-center study.
Gao X; Cui J; Wang L; Wang Q; Ma T; Yang J; Ye Z
Front Oncol; 2023; 13():1205163. PubMed ID: 37388227
[TBL] [Abstract][Full Text] [Related]
11. The clinical value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) semi-quantitative parameters in monitoring neoadjuvant chemotherapy response of osteosarcoma.
Zeng YN; Zhang BT; Song T; Peng JF; Wang JT; Yuan Q; Tan MY
Acta Radiol; 2022 Aug; 63(8):1077-1085. PubMed ID: 34247514
[TBL] [Abstract][Full Text] [Related]
12. Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer.
Zhang B; Yu Y; Mao Y; Wang H; Lv M; Su X; Wang Y; Li Z; Zhang Z; Bian T; Wang Q
Acad Radiol; 2024 Mar; 31(3):800-811. PubMed ID: 37914627
[TBL] [Abstract][Full Text] [Related]
13. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
14. Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization.
Dong W; Xiong S; Lei P; Wang X; Liu H; Liu Y; Zou H; Fan B; Qiu Y
Front Oncol; 2022; 12():944005. PubMed ID: 36081562
[TBL] [Abstract][Full Text] [Related]
15. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
[TBL] [Abstract][Full Text] [Related]
16. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
17. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients.
Chen S; Shu Z; Li Y; Chen B; Tang L; Mo W; Shao G; Shao F
Front Oncol; 2020; 10():1410. PubMed ID: 32923392
[No Abstract] [Full Text] [Related]
19. Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.
Zeng Q; Ke M; Zhong L; Zhou Y; Zhu X; He C; Liu L
Acad Radiol; 2023 Aug; 30(8):1638-1647. PubMed ID: 36564256
[TBL] [Abstract][Full Text] [Related]
20. Machine learning for predicting breast-conserving surgery candidates after neoadjuvant chemotherapy based on DCE-MRI.
Chen Z; Huang M; Lyu J; Qi X; He F; Li X
Front Oncol; 2023; 13():1174843. PubMed ID: 37621690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
